A CRISPR/Cas9-Engineered <i>ARID1A</i> -Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic TransformationYuan‐Hung Lo, Calvin J. Kuo, A. Krokhotin et al.|Cancer Discovery|2021Cited by 166
Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoidsBauer L. LeSavage, Sarah C. Heilshorn, D.H. Zhang et al.|Nature Materials|2024Cited by 86